Background Genome-wide association studies (GWAS) in Parkinson's disease have increased
the scope of biological knowledge about the disease over the past decade. We aimed to …

Objective: To evaluate the association between diagnosis of Parkinson disease (PD) and
risk factors or early symptoms amenable to population‐based screening. Methods: A …

Background Increasing evidence supports an extensive and complex genetic contribution to
PD. Previous genome‐wide association studies (GWAS) have shed light on the genetic …

Background Accurate diagnosis and early detection of complex diseases, such as Parkinson's
disease, has the potential to be of great benefit for researchers and clinical practice. We …

Objective To systematically review published literature to estimate the magnitude of association
between premorbid constipation and later diagnosis of Parkinson's disease. Background …

… Noyce has received grants from Parkinson's UK, Élan/Prothena Pharmaceuticals, GE
Healthcare; advisory board membership for myHealthPal; honoraria from Office Octopus, Henry …

Background Type 2 diabetes (T2DM) and Parkinson's disease (PD) are prevalent diseases
that affect an aging population. Previous systematic reviews and meta‐analyses have …

GTP cyclohydrolase 1, encoded by the GCH1 gene, is an essential enzyme for dopamine
production in nigrostriatal cells. Loss-of-function mutations in GCH1 result in severe reduction …

Importance Substantial genome-wide association study (GWAS) work in Parkinson disease (PD)
has led to the discovery of an increasing number of loci shown reliably to be associated …

Parkinson’s disease is a genetically complex disorder. Multiple genes have been shown to
contribute to the risk of Parkinson’s disease, and currently 90 independent risk variants have …